Register
SEC Form 4 insider trading filings tracked in real time from EDGAR

Nicholson Nur — Chief Technical Officer

Insider trading activity for Nicholson Nur sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Technical Officer
  • Company: Apellis Pharmaceuticals, Inc.
  • Total insider trades: 19
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: May 14, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 28,367 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 35,472 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 45,000 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 50,974 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 115,281 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 82,500 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 45,220 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 27,320 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 9,754 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 5,645 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 41,250 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. BUY 41,250 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 24,284 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. BUY 24,284 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 45,220 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. BUY 45,220 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. SELL 22,610 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. BUY 22,610 N/A
May 14, 2026 Nicholson Nur APLS Apellis Pharmaceuticals, Inc. OTHER 116,338 N/A

← All executives · Full trades feed